Not a good buy right now for an impatient entry: price (~38.17 pre-market) is below the key pivot (41.51) with bearish-to-neutral momentum, so odds favor chop/down before any cleaner upside.
Upside is less compelling at current levels because the latest Wall St. target cited ($35) is already below today’s price, suggesting the stock is ahead of that analyst’s valuation.
If you already own it, holding is reasonable given strong recent fundamentals and a supportive U.S. critical-minerals policy headline; but for a new buy, the setup is not attractive today without a technical reclaim of 41.51.
Influential / political activity: No recent congress trading data available; hedge funds and insiders are neutral with no notable recent trend.
Technical Analysis
Trend/Momentum: MACD histogram at -0.834 (below zero) = bearish momentum, though “negatively contracting” hints selling pressure may be easing rather than accelerating.
RSI(6) ~40.47: slightly weak/soft (not oversold), implying room for further downside before a reflexive bounce becomes likely.
Moving averages: converging MAs = consolidation/indecision; not a confirmed uptrend.
Key levels: Resistance/pivot at 41.51 (needs reclaim for bullish confirmation). Support S1 at 36.67 (near-term downside magnet if weakness persists), then S2 at 33.68. Upside levels: R1 46.35, R2 49.34 if 41.51 is regained.
Pattern-based forward bias (from similar candlesticks): modest 1-day upside probability, but negative 1-week expectation (-2.75%), with a more constructive 1-month expectation (+3.66%)—i.e., near-term still shaky.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning/Sentiment: Open interest put/call ratio 0.35 is call-heavy (bullish positioning), while volume put/call 0.81 is only mildly call-favored (not an aggressive risk-on reading).
Volatility: IV ~100% and IV percentile ~86.8 = very expensive options / elevated uncertainty; this often coincides with sharp moves but also increases the chance of IV crush after catalysts.
Activity: Total OI ~14,285 with today vs. OI avg ~112.55 suggests OI is elevated/active, but today’s volume (270) is below recent 5D/10D averages (483/409), implying no strong “today” conviction spike.
Technical Summary
Sell
7
Buy
5
Positive Catalysts
supports a higher-quality narrative versus many small resource peers.
Neutral/Negative Catalysts
with MACD still negative—near-term trend is not decisively bullish.
Net income: $2.97M, +87.52% YoY (profit growth outpacing revenue).
EPS: $0.20, +66.67% YoY.
Gross margin: 63.6%, +30.57% YoY (material improvement in profitability/efficiency).
Takeaway: Clear positive growth trend, supportive for a medium-term thesis—even if the near-term chart is not offering a clean entry today.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Most recent cited update (2025-11-17): Roth Capital reiterated Buy and raised the price target to $35 from $30.
Trend summary: Rating stayed positive (Buy maintained), target moved up (bullish revision at the time).
Wall St. pros: Efficient operations + strong commodity pricing backdrop cited as key positives.
Wall St. cons (based on today’s pricing vs target): With shares around ~38 pre-market, the stock is trading above the cited $35 target—reducing implied upside and making “buy right now” less compelling unless price action improves (e.g., reclaiming 41.51).
Wall Street analysts forecast IDR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IDR is 45 USD with a low forecast of 45 USD and a high forecast of 45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast IDR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IDR is 45 USD with a low forecast of 45 USD and a high forecast of 45 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 34.580
Low
45
Averages
45
High
45
Current: 34.580
Low
45
Averages
45
High
45
Roth Capital
Buy
maintain
$30 -> $35
AI Analysis
2025-11-17
Reason
Roth Capital
Price Target
$30 -> $35
AI Analysis
2025-11-17
maintain
Buy
Reason
Roth Capital raised the firm's price target on Idaho Strategic to $35 from $30 and keeps a Buy rating on the shares. Idaho Strategic is benefiting from exceptionally efficient operations and record gold prices to fund its production backed business plan, the analyst tells investors in a research note.
Roth Capital
Buy
maintain
$25 -> $30
2025-09-08
Reason
Roth Capital
Price Target
$25 -> $30
2025-09-08
maintain
Buy
Reason
Roth Capital raised the firm's price target on Idaho Strategic to $30 from $25 and keeps a Buy rating on the shares. The firm's recent visit to its projects in the Idaho REE-Thorium Belt near Salmon, Idaho, confirm that it may have one of the world's most prospective undeveloped REE-thorium projects, the analyst tells investors in a research note. Idaho Strategic has the wind at its back, with record gold prices and strategic minerals, and it is now realizing the benefits of years building culture, capital structure and opportunities, the firm added.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IDR